Enzo Biochem, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Supplemental disclosure for statement of cash flows

Supplemental disclosure for statement of cash flows	12 Months Ended
Jul. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	Note 3 - Supplemental disclosure for statement of cash flows In the years ended July 31, 2017, 2016, and 2015, income taxes paid by the Company approximated $1,021, $279, and $115 respectively. In the years ended July 31, 2017, 2016, and 2015, interest paid by the Company approximated $119, $121, and $206 respectively. During fiscal 2017, 2016 and 2015, the Company financed $69, $95 and $346, respectively, in machinery and transportation equipment under installment loans. During fiscal 2017, the Company did not enter into any capital lease agreements. During fiscal 2016 and 2015, the Company entered into capital lease agreements for machinery and equipment with a cost basis of $1,280 and $155, respectively. During fiscal 2015, the Company recorded $45 in additional paid in capital and reduced accrued liabilities by the same amount for options issued in lieu of cash payment of certain incentive compensation awards. There were no such transactions recorded during fiscal 2017 or 2016.

Supplemental disclosure for statement of cash flows

12 Months Ended

Jul. 31, 2017

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Note 3 - Supplemental disclosure for statement of cash flows

In the years ended July 31, 2017, 2016, and 2015, income taxes paid by the Company approximated $1,021, $279, and $115 respectively.

In the years ended July 31, 2017, 2016, and 2015, interest paid by the Company approximated $119, $121, and $206 respectively.

During fiscal 2017, 2016 and 2015, the Company financed $69, $95 and $346, respectively, in machinery and transportation equipment under installment loans.

During fiscal 2017, the Company did not enter into any capital lease agreements. During fiscal 2016 and 2015, the Company entered into capital lease agreements for machinery and equipment with a cost basis of $1,280 and $155, respectively.

During fiscal 2015, the Company recorded $45 in additional paid in capital and reduced accrued liabilities by the same amount for options issued in lieu of cash payment of certain incentive compensation awards. There were no such transactions recorded during fiscal 2017 or 2016.